Janus Henderson Group PLC Apellis Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 34,412 shares of APLS stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,412
Previous 34,939
1.51%
Holding current value
$1.12 Million
Previous $2.05 Million
35.7%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$533 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$377 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$361 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$319 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$188 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.57B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...